What one share of Embecta holds
Building on our 100-year centennial, we believe that our products have become one of the most widely recognized and respected brands in diabetes management throughout the world. We estimate that our products are used by more than 30 million people in over 100 countries for insulin administration and to aid with the daily management of diabetes.
Embecta’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $17.10 |
|---|---|
| Profit | $1.47 |
| Capex (buildings and equipment) | $0.16 |
| Free cash flow | $2.76 |
| Dividends | $0.46 |
| Cash and investments | $3.79 |
| Debt | $26.23 |
| Book value | −$10.81 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | $19.04 | $7.50 | $0.73 | $8.01 | — | $10.04 |
| 2021 | $20.44 | $7.28 | $0.65 | $7.36 | — | $10.42 |
| 2022 | $19.66 | $3.89 | $0.41 | $6.76 | $0.15 | −$15.62 |
| 2023 | $19.41 | $1.22 | $0.46 | $0.71 | $0.60 | −$14.33 |
| 2024 | $19.26 | $1.34 | $0.27 | $0.34 | $0.60 | −$12.79 |
| 2025 | $18.34 | $1.62 | $0.16 | $3.10 | $0.60 | −$11.12 |
Common questions about Embecta
How much does one share of Embecta earn?
Over the last 12 months, each share of Embecta earned $1.47 of profit on $17.10 of sales, keeping about 9¢ of every $1 (profit margin).
Does Embecta pay a dividend?
Yes. Embecta paid $0.46 per share in dividends over the last 12 months, and it paid a dividend in every year from 2022 to 2025 in StockSlicer’s data. That’s about 31¢ of each $1 of profit (payout ratio).
What is Embecta’s book value per share?
Embecta’s book value is negative (−$10.81 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Embecta have?
Each share of Embecta has $3.79 of cash and investments and $26.23 of debt, as of June 30, 2026.
What is Embecta’s free cash flow per share?
$2.76 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
How has Embecta’s profit per share changed over time?
Profit per share went from $7.50 in 2020 to $1.62 in 2025, shrinking about 26.4% a year (adjusted for stock splits).
Has Embecta bought back shares?
Embecta’s share count rose about 3% from 2020 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.